View Clinical Trial (Medical Research Study)
Safety and Efficacy of AGN 210699 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma - NCT00809848-(Clinical Trial 260116)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Artesia |
|
State:
|
|
CA |
| Zip Code: |
|
|
| Conditions: |
|
Ocular Hypertension - Glaucoma |
| Purpose: |
|
The study will evaluate the safety and efficacy of AGN 210669 ophthalmic solution in
comparison with AGN 210669 vehicle and bimatoprost ophthalmic solution dosed once-daily each
morning, in subjects with ocular hypertension or primary open-angle glaucoma. Subjects will
be followed for 2 weeks.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Ocular hypertension or primary open-angle glaucoma
- Females of non-childbearing potential
- Subject requires IOP-lowering therapy in both eyes
- IOP ≥ 22 mm Hg and ≤ 34 mm Hg
- Has a visual acuity score of 20/100 or better in each eye
Exclusion Criteria:
- Uncontrolled systemic disease
- Active ocular disease
- Alteration of existing chronic systemic medications
- Known allergy or sensitivity to the study medications
- Ophthalmic corticosteroids
- Visual field loss which in the opinion of the investigator is functionally
significant
- History of ocular laser, intraocular surgery, or refractive surgery |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
September 9, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|